We are monitoring the impact of COVID-19 on Europe Preclinical CRO Agents Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 6463
Share on
Share on

Europe Preclinical CRO Agents Market Research Report - Segmented By Service Type, By End User & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts | 2019-2024

Pulished: August, 2019
ID: 6463
Pages: 145

Europe Preclinical CRO Agents Market Size & Growth (2019 - 2024)

As per the research report, the size of the Europe Preclinical CRO Agents Market is valued at USD 1.02 billion in 2019 and estimated to be growing at a CAGR of 8.11%, to reach USD 1.39 billion by 2024 during the forecast period 2019-2024. 

A preclinical contact research organization is the guiding force for pharmaceutical companies advising how to take a drug from the research laboratories to the market. It requires various professionals including medical personnel, administrators and marketing experts. Preclinical research is of prime importance and has various risks associated with it. This is the phase where there is a high chance that a product might fail and hence choosing a CRO becomes of prime importance.

Increasing number of life science of companies and outsourcing of various functions is driving the market growth. The rising number of R&D projects in the clinical phase segment are further propelling the market growth. Due to the failure of toxicology tests, the market is growing significantly. Supportive government policies regarding drug approval is expected to fuel the market growth during the forecast period.

This research report segmented and sub-segmented into the following categories:

  • By Service Type: bioanalysis And DMPK Studies, Toxicology Testing and Other Preclinical Services
  • By End User: Biopharmaceutical Companies, Government and Academic Institutes and Medical Device Companies
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Europe is the second largest market for preclinical CRO.

Key players operating in the Europe Preclinical CRO Agents Market profiled in this report are Charles River Laboratories International, Inc.; Laboratory Corporation of America; Envigo, Eurofins Scientific; PRA Health Science, Inc.; Wuxi AppTec; Medpace, Inc.; Pharmaceutical Product Development, LLC.; and Paraxel International Corporation.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Service type                               

                                5.1.1 Introduction           

                                5.1.2 Bioanalysis and DMPK studies        

                                5.1.3 Toxicology testing

                                5.1.4 Other preclinical services  

                                5.1.5  Y-o-Y Growth Analysis, By service type      

                                5.1.6  Market Attractiveness Analysis, By service type    

                                5.1.7  Market Share Analysis, By service type     

                5.2 End user                      

                                5.2.1 Introduction           

                                5.2.2 Biopharmaceutical companies        

                                5.2.3 Government and academic institutes         

                                5.2.4 Medical device companies               

                                5.2.5 Y-o-Y Growth Analysis, By end user             

                                5.2.6 Market Attractiveness Analysis, By end user           

                                5.2.7 Market Share Analysis, By end user             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By service type

                                                6.1.3.3 By end user

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By service type

                                                6.1.4.3 By end user

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By service type

                                                6.1.5.3 By end user

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Charles River Laboratories International, Inc                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Laboratory Corporation of America                  

                8.3 Envigo                           

                8.4 Eurofins Scientific                    

                8.5 PRA Health Science, Inc                         

                8.6 Wuxi AppTec                             

                8.7 Medpace, Inc                            

                8.8 Pharmaceutical Product Development, LLC                  

                8.9 Paraxel International Corporation                    

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by end user along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  2. Europe Bioanalysis and DMPK studies Market By Region, From 2019-2024 ( USD Billion )
  3. Europe Toxicology testing Market By Region, From 2019-2024 ( USD Billion )
  4. Europe Other preclinical services Market By Region, From 2019-2024 ( USD Billion )
  5. Europe Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  6. Europe Biopharmaceutical companies Market By Region, From 2019-2024 ( USD Billion )
  7. Europe Govermenta and academic institutes Market By Region, From 2019-2024 ( USD Billion )
  8. Europe Medical device companies Market By Region, From 2019-2024 ( USD Billion )
  9. U.K. Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  10. U.K. Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  11. Germany Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  12. Germany Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  13. France Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  14. France Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  15. Italy Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  16. Italy Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )
  17. Spain Preclinical CRO Market By Service type, From 2019-2024 ( USD Billion )
  18. Spain Preclinical CRO Market By End user, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample